Prognostic factors and long-term survival in renal cell cancer patients

Scandinavian Journal of Urology and Nephrology

Volumn 43, Issue 6, 2009, Pages 454-460

  Sunela, Kaisa L ^a   Kataja, Matti J ^b   Lehtinen, Eero T ^a   Salminen, Tapio K ^a   Kujala, Paula M ^a   Virman, Juha P ^b   Kellokumpu Lehtinen, Pirkko Liisa I ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Prognosis; Renal cell carcinoma; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BAYES THEOREM; CARCINOMA, RENAL CELL; CHILD; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; SURVIVORS; YOUNG ADULT;

EID: 72049129693     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365590903286697     Document Type: Article

References (23)

1. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003;30:843-852
2. Beck SDW, Patel MI, Snyder ME, Kattan MW, Motzer RJ, Reuter VE, et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol 2003;11:71-77
3. Motzer RJ, Bacik J, Mariani T, Russo P, Mazumdar M, Reuter V. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 2002;20:2376-2381
4. Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 2000;163:1090-1095
5. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000;163:442-445
6. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, et al. Renal cell carcinoma with retroperitoneal lymph nodes - impact on survival and benefits of immunotherapy. Cancer 2003;97:2995-3002. (Pubitemid 36676253)
7. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, et al. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 2003;169:2076-2083 (Pubitemid 36576722)
8. Griffiths DFR, Verghese A, Golash A, Kynaston HG, Matthews PN, Hart AJL, et al. Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma. BJU Int 2002;90:26-31.
9. Lieber MM, Tomera FM, Taylor WF, Farrow GM. Renal adenocarcinoma in young adults: survival and variables affecting prognosis. J Urol 1981;125:164-168
10. Schips L, Lipsky K, Zigeuner R, Salfellner M, Winkler S, Langner C, et al. Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a singlecenter experience of 683 patients. Urology 2003;62:1024-1028
11. Harada K, Sakai I, Ishimura T, Inoue T, Hara I, Miyake H. Clinical symptoms in localized renal cell carcinoma reflect its invasive potential: comparative study between incidentally detected and symptomatic diseases. Urol Oncol 2006;24:201-206
12. Patard JJ, Leray E, Rodriguez A, Rioux-Leclercq N, Guillé F, Lobel B. Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol 2003;44:226-232
13. Patard JJ, Leray E, Cindolo L, Ficarra V, Rodriguez A, de la Taille A, et al. Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 2004;172:858-862
14. Kim HL, Belldegrun AS, Freitas DG, Bui MHT, Han KR, Dorey FJ, et al. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis. J Urol 2003;170:1742-1746
15. Uno M, Fujimoto Y, Takada T, Ishida K, Kubota Y, Katoh S, et al. Prognostic factors for survival of patients after curative surgery for renal cell carcinoma: multivariate analysis of 482 cases. Int J Clin Oncol 2004;9:510-514
16. Lee SE, Byun SS, Han JH, Han BK, Hong SK. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma. BJU Int 2006;98:1228-1232
17. Sengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, et al. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer 2006;106:304-312
18. Hakulinen T. On long-term relative survival rates. J Chron Dis 1977;30:431-443
19. McNichols DW, Segura JW, DeWeerd JH. Renal cell carcinoma: long-term survival and late recurrence. J Urol 1981;126:17-23.
20. Bretheau D, Lechevallier E, Eghazarian C, Grisoni V, Coulange C. Prognostic significance of incidental renal cell carcinoma. Eur Urol 1995;27:319-323
21. Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma - age and stage characterization and clinical implications: study of 1092 patients (1982-2000). Urology 2000;56:58-62.
22. Gudbjartsson T, Thoroddsen A, Petursdottir V, Hardarson S, Magnusson J, Einarsson GV. Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology 2005;66:1186-1191
23. Bos SD, Mellema CT, Mensink HJA. Increase in incidental renal cell carcinoma in the northern part of the Netherlands. Eur Urol 2000;37:267-270.